Clinical study of administration of alpha-GalactosylCeramide-pulsed DCs by bronchoscopy in patients with either advanced or recurrent non-small cell lung cancer (NSCLC)
Phase 1
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000005208
- Lead Sponsor
- Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have: uncontrolled diabetes mellitus, pulmonary fibrosis, and/or infection; synchronous multiple cancer; a history of hepatitis; a positive response for hepatitis B surface antigen, hepatitis C virus, or human immunodeficiency virus (HIV), or human T-lymphotrophic virus antibodies; serious cardiac diseases; pregnancy or lactation; autoimmune diseases; been judged to be inappropriate to practice in this study by principle investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method The clinical effects and immunological responses